The term ‘psychotropic drug’ is used to define medication that acts on the central nervous system by modifying certain mental processes. Generally speaking, these are medicines used to treat mild or serious mental illness and to alleviate pain.
Due to their psychoactive properties, psychotropic medicines may cause dependency if used chronically or if abused.
Psychotropic medication is sometimes consumed outside any medical context and may be misappropriated or even trafficked in the same way as illegal drugs.
France’s Interministerial Mission to Combat Drugs and Drug Addiction (MILDT) asked Inserm to produce a collective expert opinion on the consumption of psychotropic medication and the misuse and drug dependency associated therewith so that a scientific light can be thrown on these phenomena, with the addition of useful recommendations for improving the regulations and current prevention and care arrangements in France.
To comply this request, Inserm has created a multi-disciplinary group of 11 experts in the fields of epidemiology, drug monitoring, public health, sociology, anthropology, toxicology, psychiatry and neurobiology. The group analysed more than 1100 international scientific publications, making it possible to report on the main findings concerning the French situation.
Principal classes of psychotropic drugs
|Class of psychotropic drugs
|Anxiolytics or tranquillisers
|Hypnotics or sleeping pills
|Neuroleptics or antipsychotics
||Typical neuroleptics typiques
||Inhibitors of serotonin reuptake
||Inhibitors of noradrenaline reuptake
||Inhibitors of serotonin catabolism (IMAO)
||High Dosage Buprenorphine
What is Inserm’s Collective Expert Opinion Centre?
Collective expertise has been an Inserm initiative since 1994. More than seventy collective expert opinions have been produced in numerous healthcare fields.
Inserm’s Collective Expert Opinions throw scientific light on a given healthcare subject based on critical analysis and a summary of the international scientific literature. It is performed at the request of institutions that need recent data produced from research to help them in their decision-making process with respect to public policy. The Expert Opinion should be considered as the initial stage necessary to result in decision-making in the long term.
In response to the issue in question, Inserm brings together a multidisciplinary group of recognised experts consisting of scientists and doctors. These experts meet, analyse scientific publications and summarise them. The salient points are extracted and recommendations are often made.
The conclusions obtained through the collective effort of experts contributes to the debate of healthcare professionals involved and the social debate.